Anna Pons-Grífols

6PUBLICATIONS
30CO-AUTHORS
Gene and molecular therapyAgricultural molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Animal reproduction and breedingInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2025
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Anna Pons-Grífols, Ferran Tarrés-Freixas, Mònica Pérez

|Jun 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.

Raquel Ortiz, Ana Barajas, Anna Pons-Grífols

|Mar 22, 2024
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo

|Feb 05, 2024
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.

Leire de Campos-Mata, Benjamin Trinité, Andrea Modrego

|May 27, 2023
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.

Raquel Ortiz, Ana Barajas, Anna Pons-Grífols

|Apr 06, 2023
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.

Ferran Tarrés-Freixas, Carmen Aguilar-Gurrieri, María Luisa Rodríguez de la Concepción

Pageof 1

Frequent Collaborators

6 joint publications

Benjamin Trinité

6 joint publications

Julià Blanco

5 joint publications

Victor Urrea

3 joint publications

Edwards Pradenas